United States — Food and Drug Administration & Hagens Berman
11 shared events · Importance 3 · Last updated Aug 20, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.
Hagens Berman: Hagens Berman is investigating claims that ImmunityBio violated federal securities laws and is urging investors with significant losses to join their class action lawsuit.
Apr 02, 2026 · 132 articles
Regulatory
United States — Food and Drug Administration: The FDA issued a warning letter to Medline citing manufacturing violations, which triggered the investigation and market decline.
Hagens Berman: HBSS is leading the investigation into Medline, representing shareholders and seeking to uncover potential securities law violations.
Jul 01, 2026 · 6 articles
Regulatory
United States — Food and Drug Administration: The FDA placed a full clinical hold on ARD-101's IND, halting all ongoing studies. This regulatory action is central to the lawsuit and has severely impacted Aardvark's operations and stock price.
Hagens Berman: Hagens Berman is another law firm that announced the class action and is investigating the claims. The firm represents investors and whistleblowers and may benefit from a successful outcome.
Aug 14, 2026 · 23 articles
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Hagens Berman: Filed a class action lawsuit against Capricor.
Jul 27, 2026 · 293 articles
Regulatory
United States — Food and Drug Administration: The FDA is cited in the lawsuit regarding the lack of a known safe level of lead exposure, but is not directly involved in the case.
Hagens Berman: Hagens Berman is the law firm representing the plaintiffs in the class action lawsuit. The firm is known for consumer protection cases.
Jul 09, 2026 · 8 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Hagens Berman interact across events, view sentiment trends, and discover connected entities.
Open Dashboard